Clear Harbor Asset Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,000
Closed -$147K 446
2025
Q2
$147K Sell
13,000
-4,950
-28% -$53.7K 0.01% 393
2025
Q1
$181K Sell
17,950
-12,850
-42% -$139K 0.01% 374
2024
Q4
$364K Hold
30,800
0.03% 288
2024
Q3
$355K Hold
30,800
0.03% 273
2024
Q2
$326K Buy
30,800
+500
+2% +$5.48K 0.03% 281
2024
Q1
$319K Buy
30,300
+18,200
+150% +$196K 0.03% 285
2023
Q4
$136K Buy
+12,100
New +$118K 0.01% 343

Other funds holding ROIV

Clear Harbor Asset Management's ROIV Position: Q3 2025 in Review

Clear Harbor Asset Management sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 13,000 shares — an estimated $147K sold.

Clear Harbor Asset Management first reported a position in ROIV in Q4 2023 and held it in 7 quarters. The position peaked at $364K in Q4 2024. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Clear Harbor Asset Management reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Clear Harbor Asset Management sold 13,000 Roivant Sciences shares in Q3 2025, an estimated $147K.
  • Clear Harbor Asset Management first reported a position in Roivant Sciences in Q4 2023 and held it in 7 quarters.
  • Clear Harbor Asset Management's Roivant Sciences position peaked at $364K in Q4 2024.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Clear Harbor Asset Management's 13F filing for Q3 2025, filed 23 Oct 2025.